ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Emergency Contraceptives - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-23R3938
Home | Market Reports | Health| Reproductive Health
Global Emergency Contraceptives Market Research Report 2021
BUY CHAPTERS

Emergency Contraceptives - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-23R3938
Report
September 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Genetics
Teva Pharmaceutical
Uniprix
Gavis Pharmaceuticals
HRA Pharma
Mankind Pharma

Emergency Contraceptives - Market Size

The global market for Emergency Contraceptives was estimated to be worth US$ 568 million in 2023 and is forecast to a readjusted size of US$ 936.7 million by 2030 with a CAGR of 7.4% during the forecast period 2024-2030

Emergency Contraceptives - Market

Emergency Contraceptives - Market

The emergency contraceptives market refers to the industry involved in the production, distribution, and sale of medications and products used for emergency contraception. Emergency contraceptives, also known as "morning-after pills," are designed to prevent pregnancy after unprotected intercourse or contraceptive failure.
The emergency contraceptives market is a segment within the broader contraceptive industry. It focuses on providing women with safe and effective options for emergency contraception when regular contraceptive methods have failed, were not used, or in cases of sexual assault.
The emergency contraceptives market is influenced by factors such as changing societal norms, increasing awareness of contraception options, rising demand for reproductive healthcare services, and initiatives to reduce unintended pregnancies. Additionally, the market is driven by advancements in emergency contraceptive formulations and the expansion of distribution channels.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Emergency Contraceptives, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Emergency Contraceptives by region & country, by Type, and by Application.
The Emergency Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emergency Contraceptives.
Market Segmentation

Scope of Emergency Contraceptives - Market Report

Report Metric Details
Report Name Emergency Contraceptives - Market
Forecasted market size in 2030 US$ 936.7 million
CAGR 7.4%
Forecasted years 2024 - 2030
Segment by Type:
  • Combined Estrogen and Progestin Pills
  • Progestin-Only (As Levonorgestrel) Pills
  • Antiprogestin (As Mifepristone) Pills
  • Ulipristal Acetate Pills
Segment by Application
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Genetics, Teva Pharmaceutical, Uniprix, Gavis Pharmaceuticals, HRA Pharma, Mankind Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Emergency Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Emergency Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Emergency Contraceptives in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Emergency Contraceptives - Market size in 2030?

Ans: The Emergency Contraceptives - Market size in 2030 will be US$ 936.7 million.

Who are the main players in the Emergency Contraceptives - Market report?

Ans: The main players in the Emergency Contraceptives - Market are Genetics, Teva Pharmaceutical, Uniprix, Gavis Pharmaceuticals, HRA Pharma, Mankind Pharma

What are the Application segmentation covered in the Emergency Contraceptives - Market report?

Ans: The Applications covered in the Emergency Contraceptives - Market report are Hospital pharmacies, Retail pharmacies, Online pharmacies, Others

What are the Type segmentation covered in the Emergency Contraceptives - Market report?

Ans: The Types covered in the Emergency Contraceptives - Market report are Combined Estrogen and Progestin Pills, Progestin-Only (As Levonorgestrel) Pills, Antiprogestin (As Mifepristone) Pills, Ulipristal Acetate Pills

1 Market Overview
1.1 Emergency Contraceptives Product Introduction
1.2 Global Emergency Contraceptives Market Size Forecast
1.2.1 Global Emergency Contraceptives Sales Value (2019-2030)
1.2.2 Global Emergency Contraceptives Sales Volume (2019-2030)
1.2.3 Global Emergency Contraceptives Sales Price (2019-2030)
1.3 Emergency Contraceptives Market Trends & Drivers
1.3.1 Emergency Contraceptives Industry Trends
1.3.2 Emergency Contraceptives Market Drivers & Opportunity
1.3.3 Emergency Contraceptives Market Challenges
1.3.4 Emergency Contraceptives Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Emergency Contraceptives Players Revenue Ranking (2023)
2.2 Global Emergency Contraceptives Revenue by Company (2019-2024)
2.3 Global Emergency Contraceptives Players Sales Volume Ranking (2023)
2.4 Global Emergency Contraceptives Sales Volume by Company Players (2019-2024)
2.5 Global Emergency Contraceptives Average Price by Company (2019-2024)
2.6 Key Manufacturers Emergency Contraceptives Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Emergency Contraceptives Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Emergency Contraceptives
2.9 Emergency Contraceptives Market Competitive Analysis
2.9.1 Emergency Contraceptives Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Emergency Contraceptives Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emergency Contraceptives as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Combined Estrogen and Progestin Pills
3.1.2 Progestin-Only (As Levonorgestrel) Pills
3.1.3 Antiprogestin (As Mifepristone) Pills
3.1.4 Ulipristal Acetate Pills
3.2 Global Emergency Contraceptives Sales Value by Type
3.2.1 Global Emergency Contraceptives Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Emergency Contraceptives Sales Value, by Type (2019-2030)
3.2.3 Global Emergency Contraceptives Sales Value, by Type (%) (2019-2030)
3.3 Global Emergency Contraceptives Sales Volume by Type
3.3.1 Global Emergency Contraceptives Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Emergency Contraceptives Sales Volume, by Type (2019-2030)
3.3.3 Global Emergency Contraceptives Sales Volume, by Type (%) (2019-2030)
3.4 Global Emergency Contraceptives Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital pharmacies
4.1.2 Retail pharmacies
4.1.3 Online pharmacies
4.1.4 Others
4.2 Global Emergency Contraceptives Sales Value by Application
4.2.1 Global Emergency Contraceptives Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Emergency Contraceptives Sales Value, by Application (2019-2030)
4.2.3 Global Emergency Contraceptives Sales Value, by Application (%) (2019-2030)
4.3 Global Emergency Contraceptives Sales Volume by Application
4.3.1 Global Emergency Contraceptives Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Emergency Contraceptives Sales Volume, by Application (2019-2030)
4.3.3 Global Emergency Contraceptives Sales Volume, by Application (%) (2019-2030)
4.4 Global Emergency Contraceptives Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Emergency Contraceptives Sales Value by Region
5.1.1 Global Emergency Contraceptives Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Emergency Contraceptives Sales Value by Region (2019-2024)
5.1.3 Global Emergency Contraceptives Sales Value by Region (2025-2030)
5.1.4 Global Emergency Contraceptives Sales Value by Region (%), (2019-2030)
5.2 Global Emergency Contraceptives Sales Volume by Region
5.2.1 Global Emergency Contraceptives Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Emergency Contraceptives Sales Volume by Region (2019-2024)
5.2.3 Global Emergency Contraceptives Sales Volume by Region (2025-2030)
5.2.4 Global Emergency Contraceptives Sales Volume by Region (%), (2019-2030)
5.3 Global Emergency Contraceptives Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Emergency Contraceptives Sales Value, 2019-2030
5.4.2 North America Emergency Contraceptives Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Emergency Contraceptives Sales Value, 2019-2030
5.5.2 Europe Emergency Contraceptives Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Emergency Contraceptives Sales Value, 2019-2030
5.6.2 Asia Pacific Emergency Contraceptives Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Emergency Contraceptives Sales Value, 2019-2030
5.7.2 South America Emergency Contraceptives Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Emergency Contraceptives Sales Value, 2019-2030
5.8.2 Middle East & Africa Emergency Contraceptives Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Emergency Contraceptives Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Emergency Contraceptives Sales Value
6.2.1 Key Countries/Regions Emergency Contraceptives Sales Value, 2019-2030
6.2.2 Key Countries/Regions Emergency Contraceptives Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Emergency Contraceptives Sales Value, 2019-2030
6.3.2 United States Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Emergency Contraceptives Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Emergency Contraceptives Sales Value, 2019-2030
6.4.2 Europe Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Emergency Contraceptives Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Emergency Contraceptives Sales Value, 2019-2030
6.5.2 China Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
6.5.3 China Emergency Contraceptives Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Emergency Contraceptives Sales Value, 2019-2030
6.6.2 Japan Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Emergency Contraceptives Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Emergency Contraceptives Sales Value, 2019-2030
6.7.2 South Korea Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Emergency Contraceptives Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Emergency Contraceptives Sales Value, 2019-2030
6.8.2 Southeast Asia Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Emergency Contraceptives Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Emergency Contraceptives Sales Value, 2019-2030
6.9.2 India Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
6.9.3 India Emergency Contraceptives Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Genetics
7.1.1 Genetics Company Information
7.1.2 Genetics Introduction and Business Overview
7.1.3 Genetics Emergency Contraceptives Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Genetics Emergency Contraceptives Product Offerings
7.1.5 Genetics Recent Development
7.2 Teva Pharmaceutical
7.2.1 Teva Pharmaceutical Company Information
7.2.2 Teva Pharmaceutical Introduction and Business Overview
7.2.3 Teva Pharmaceutical Emergency Contraceptives Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Teva Pharmaceutical Emergency Contraceptives Product Offerings
7.2.5 Teva Pharmaceutical Recent Development
7.3 Uniprix
7.3.1 Uniprix Company Information
7.3.2 Uniprix Introduction and Business Overview
7.3.3 Uniprix Emergency Contraceptives Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Uniprix Emergency Contraceptives Product Offerings
7.3.5 Uniprix Recent Development
7.4 Gavis Pharmaceuticals
7.4.1 Gavis Pharmaceuticals Company Information
7.4.2 Gavis Pharmaceuticals Introduction and Business Overview
7.4.3 Gavis Pharmaceuticals Emergency Contraceptives Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Gavis Pharmaceuticals Emergency Contraceptives Product Offerings
7.4.5 Gavis Pharmaceuticals Recent Development
7.5 HRA Pharma
7.5.1 HRA Pharma Company Information
7.5.2 HRA Pharma Introduction and Business Overview
7.5.3 HRA Pharma Emergency Contraceptives Sales, Revenue and Gross Margin (2019-2024)
7.5.4 HRA Pharma Emergency Contraceptives Product Offerings
7.5.5 HRA Pharma Recent Development
7.6 Mankind Pharma
7.6.1 Mankind Pharma Company Information
7.6.2 Mankind Pharma Introduction and Business Overview
7.6.3 Mankind Pharma Emergency Contraceptives Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Mankind Pharma Emergency Contraceptives Product Offerings
7.6.5 Mankind Pharma Recent Development
8 Industry Chain Analysis
8.1 Emergency Contraceptives Industrial Chain
8.2 Emergency Contraceptives Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Emergency Contraceptives Sales Model
8.5.2 Sales Channel
8.5.3 Emergency Contraceptives Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Genetics
Teva Pharmaceutical
Uniprix
Gavis Pharmaceuticals
HRA Pharma
Mankind Pharma
List of Tables
    Table 1. Emergency Contraceptives Market Trends
    Table 2. Emergency Contraceptives Market Drivers & Opportunity
    Table 3. Emergency Contraceptives Market Challenges
    Table 4. Emergency Contraceptives Market Restraints
    Table 5. Global Emergency Contraceptives Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Emergency Contraceptives Revenue Market Share by Company (2019-2024)
    Table 7. Global Emergency Contraceptives Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Emergency Contraceptives Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Emergency Contraceptives Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Emergency Contraceptives Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Emergency Contraceptives Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Emergency Contraceptives
    Table 13. Global Emergency Contraceptives Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emergency Contraceptives as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Emergency Contraceptives Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Emergency Contraceptives Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Emergency Contraceptives Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Emergency Contraceptives Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Emergency Contraceptives Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Emergency Contraceptives Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Emergency Contraceptives Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Emergency Contraceptives Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Emergency Contraceptives Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Emergency Contraceptives Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Emergency Contraceptives Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Emergency Contraceptives Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Emergency Contraceptives Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Emergency Contraceptives Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Emergency Contraceptives Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Emergency Contraceptives Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Emergency Contraceptives Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Emergency Contraceptives Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Emergency Contraceptives Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Emergency Contraceptives Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Emergency Contraceptives Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Emergency Contraceptives Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Emergency Contraceptives Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Emergency Contraceptives Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Emergency Contraceptives Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Emergency Contraceptives Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Emergency Contraceptives Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Emergency Contraceptives Sales Value by Region (2019-2024) & (%)
    Table 44. Global Emergency Contraceptives Sales Value by Region (2025-2030) & (%)
    Table 45. Global Emergency Contraceptives Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Emergency Contraceptives Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Emergency Contraceptives Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Emergency Contraceptives Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Emergency Contraceptives Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Emergency Contraceptives Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Emergency Contraceptives Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Emergency Contraceptives Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Emergency Contraceptives Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Emergency Contraceptives Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Emergency Contraceptives Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Emergency Contraceptives Sales Volume, (2025-2030) & (K Units)
    Table 57. Genetics Company Information
    Table 58. Genetics Introduction and Business Overview
    Table 59. Genetics Emergency Contraceptives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Genetics Emergency Contraceptives Product Offerings
    Table 61. Genetics Recent Development
    Table 62. Teva Pharmaceutical Company Information
    Table 63. Teva Pharmaceutical Introduction and Business Overview
    Table 64. Teva Pharmaceutical Emergency Contraceptives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Teva Pharmaceutical Emergency Contraceptives Product Offerings
    Table 66. Teva Pharmaceutical Recent Development
    Table 67. Uniprix Company Information
    Table 68. Uniprix Introduction and Business Overview
    Table 69. Uniprix Emergency Contraceptives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Uniprix Emergency Contraceptives Product Offerings
    Table 71. Uniprix Recent Development
    Table 72. Gavis Pharmaceuticals Company Information
    Table 73. Gavis Pharmaceuticals Introduction and Business Overview
    Table 74. Gavis Pharmaceuticals Emergency Contraceptives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Gavis Pharmaceuticals Emergency Contraceptives Product Offerings
    Table 76. Gavis Pharmaceuticals Recent Development
    Table 77. HRA Pharma Company Information
    Table 78. HRA Pharma Introduction and Business Overview
    Table 79. HRA Pharma Emergency Contraceptives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. HRA Pharma Emergency Contraceptives Product Offerings
    Table 81. HRA Pharma Recent Development
    Table 82. Mankind Pharma Company Information
    Table 83. Mankind Pharma Introduction and Business Overview
    Table 84. Mankind Pharma Emergency Contraceptives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Mankind Pharma Emergency Contraceptives Product Offerings
    Table 86. Mankind Pharma Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Emergency Contraceptives Downstream Customers
    Table 90. Emergency Contraceptives Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Emergency Contraceptives Product Picture
    Figure 2. Global Emergency Contraceptives Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Emergency Contraceptives Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Emergency Contraceptives Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Emergency Contraceptives Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Emergency Contraceptives Report Years Considered
    Figure 7. Global Emergency Contraceptives Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Emergency Contraceptives Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Emergency Contraceptives Revenue in 2023
    Figure 10. Emergency Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Combined Estrogen and Progestin Pills Picture
    Figure 12. Progestin-Only (As Levonorgestrel) Pills Picture
    Figure 13. Antiprogestin (As Mifepristone) Pills Picture
    Figure 14. Ulipristal Acetate Pills Picture
    Figure 15. Global Emergency Contraceptives Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Emergency Contraceptives Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Emergency Contraceptives Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Emergency Contraceptives Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Emergency Contraceptives Price by Type (2019-2030) & (USD/Unit)
    Figure 20. Product Picture of Hospital pharmacies
    Figure 21. Product Picture of Retail pharmacies
    Figure 22. Product Picture of Online pharmacies
    Figure 23. Product Picture of Others
    Figure 24. Global Emergency Contraceptives Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Emergency Contraceptives Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Emergency Contraceptives Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 27. Global Emergency Contraceptives Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Emergency Contraceptives Price by Application (2019-2030) & (USD/Unit)
    Figure 29. North America Emergency Contraceptives Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Emergency Contraceptives Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Emergency Contraceptives Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Emergency Contraceptives Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Emergency Contraceptives Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Emergency Contraceptives Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Emergency Contraceptives Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Emergency Contraceptives Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Emergency Contraceptives Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Emergency Contraceptives Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Emergency Contraceptives Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Emergency Contraceptives Sales Volume (%), (2019-2030)
    Figure 41. United States Emergency Contraceptives Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Emergency Contraceptives Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Emergency Contraceptives Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Emergency Contraceptives Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Emergency Contraceptives Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Emergency Contraceptives Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Emergency Contraceptives Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Emergency Contraceptives Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Emergency Contraceptives Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Emergency Contraceptives Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Emergency Contraceptives Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Emergency Contraceptives Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Emergency Contraceptives Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Emergency Contraceptives Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Emergency Contraceptives Sales Value by Application (%), 2023 VS 2030
    Figure 62. Emergency Contraceptives Industrial Chain
    Figure 63. Emergency Contraceptives Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Postpartum Rehabilitation Therapy Instruments - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-26Q13482
Thu Nov 07 00:00:00 UTC 2024

Add to Cart

Drugs for Vaginal Fungal Infections - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-27A13667
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Preeclampsia Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39U13956
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Pregnancy & Breastfeeding Bras - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-31G13595
Mon Oct 21 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions